These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3253339)

  • 41. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 42. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug therapy for paucibacillary leprosy: WHO regimen inadequate?
    Pavithran K
    Lepr Rev; 1987 Sep; 58(3):306-8. PubMed ID: 3669872
    [No Abstract]   [Full Text] [Related]  

  • 44. Three years assessment of multidrug therapy in multibacillary leprosy cases.
    Ganapati R; Revankar CR; Pai RR
    Indian J Lepr; 1987; 59(1):44-9. PubMed ID: 3611860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
    Lavania RK; Girdhar A; Girdhar BK; Desikan KV
    Acta Leprol; 1990; 7(2):169-74. PubMed ID: 2220301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fixed duration MDT in paucibacillary leprosy (classical and modified).
    Nadkarni NJ; Grugni A; Kini MS
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A clinicopathological study of multidrug therapy in borderline tuberculoid leprosy.
    Kar PK; Arora PN; Ramasastry CV; Dhaka RS
    J Indian Med Assoc; 1994 Oct; 92(10):336-7. PubMed ID: 7822849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
    Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
    Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 50. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study.
    Kumar B; Kaur S; Kaur I
    Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Paucibacillary leprosy patients treated with multidrug therapy four years experience (1988 to 1991) in Bangladesh.
    Faruque E; Hoque AK; Ahmed J; Ahmed R; Ali A
    Nihon Rai Gakkai Zasshi; 1994 Nov; 63(3):95-8. PubMed ID: 7730212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Guinea: detection of leprosy and treatment by polychemotherapy].
    Bourée P; Carré N; Drahmane S
    Bull Soc Pathol Exot Filiales; 1988; 81(4):683-91. PubMed ID: 3219772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
    Emmanuel M; Gupte MD
    Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indeterminate leprosy: a therapeutic evaluation.
    Kar PK; Jha PK; Snehi PS
    Indian J Lepr; 1992; 64(2):163-7. PubMed ID: 1607714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A trial of polychemotherapy of leprosy in the Dakar region. Initial observations on the acceptability of the protocols used].
    Millan J; Bodian M; Naudin JC; Diouf B; Boucher P; Ndoye B; Grosset J
    Acta Leprol; 1986; 4(1):19-35. PubMed ID: 3526792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occurrence of reversal reactions in BT patients during who paucibacillary leprosy MDT (1982).
    Reddy PK
    Indian J Lepr; 1988 Jul; 60(3):453-6. PubMed ID: 3198967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple relapses in borderline leprosy--a case report.
    Ramachandran A; Seshadri PS
    Indian J Lepr; 1986; 58(4):623-5. PubMed ID: 3553362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Late reversal reactions in leprosy].
    Flageul B; Vignon-Pennamen MD; Wallach D; Pennec J; Cottenot F
    Acta Leprol; 1990; 7(2):109-17. PubMed ID: 2220295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.